US, China trials suggest a single nanodrug shot might stop bad cholesterol forever

Early-stage US and Chinese trials of gene-editing nanodrugs, including one called CTX310 tested on 15 volunteers, suggest a single injection targeting the ANGPTL3 gene could permanently lower LDL cholesterol and triglycerides, potentially replacing daily statins.